Hexanic Extract of Serenoa repens (Permixon(®)): A Review in Symptomatic Benign Prostatic Hyperplasia

The hexanic extract (HE) of Serenoa repens (Permixon(®)) is indicated for the symptomatic treatment of benign prostatic hyperplasia (BPH). The drug is the n-hexane lipidosterolic extract of the American dwarf palm tree (also known as saw palmetto). The anti-inflammatory activity of HE S. repens has...

Descripción completa

Detalles Bibliográficos
Autor principal: Blair, Hannah A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Adis Drug Evaluation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192452/
https://www.ncbi.nlm.nih.gov/pubmed/35237936
http://dx.doi.org/10.1007/s40266-022-00924-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9192452/
https://www.ncbi.nlm.nih.gov/pubmed/35237936
http://dx.doi.org/10.1007/s40266-022-00924-3

Ejemplares similares